Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Anokion
Biotech
Illumina nets new CEO—Chutes & Ladders
Illumina names new CEO after stormy summer. Biogen taps new research head. Novartis CCO steps down as executive musical chairs continues.
Max Bayer
,
Gabrielle Masson
Sep 8, 2023 9:30am
Frazier departs Merck after 30 years—Chutes & Ladders
Oct 28, 2022 9:30am
Anokion autoimmune pact rides out BMS-Celgene merger
Sep 22, 2020 10:35am
Chutes & Ladders—Alder poaches Juno executive for CEO
Jun 15, 2018 10:56am
Forma’s John Hohneker takes the reins at Anokion
Jan 18, 2018 10:45am
Lilly pens deal for Evotec spinout’s immune tolerance drugs
Aug 22, 2017 10:25am
